This report provides comprehensive information on the current therapeutic developmental pipeline of CoMentis, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. http://www.researchmoz.us/comentis-inc-product-pipeline-review-2015-report.html

1. CoMentis, Inc. - Product Pipeline Review - 2015
CoMentis, Inc. - Product Pipeline Review - 2015
Summary
Global Markets Directs, CoMentis, Inc. - Product Pipeline Review - 2015, provides an overview of the CoMentis, Inc.s pharmaceutical research and development
focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of CoMentis, Inc.s, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest
updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of CoMentis, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of CoMentis, Inc.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the CoMentis, Inc.s pipeline products
Reasons to buy
- Evaluate CoMentis, Inc.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of CoMentis, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the CoMentis, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of CoMentis, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of CoMentis, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of CoMentis, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 3
list Of Figures 3
comentis, Inc. Snapshot 4
comentis, Inc. Overview 4
key Information 4
key Facts 4
comentis, Inc. - Research And Development Overview 5
key Therapeutic Areas 5
comentis, Inc. - Pipeline Review 7
pipeline Products By Stage Of Development 7
pipeline Products - Monotherapy 8
comentis, Inc. - Pipeline Products Glance 9
comentis, Inc. - Clinical Stage Pipeline Products 9
phase Ii Products/combination Treatment Modalities 9
CoMentis, Inc. - Product Pipeline Review - 2015

2. comentis, Inc. - Early Stage Pipeline Products 10
preclinical Products/combination Treatment Modalities 10
comentis, Inc. - Drug Profiles 11
gts-21 11
product Description 11
mechanism Of Action 11
r&d Progress 11
grl-8234 13
product Description 13
mechanism Of Action 13
r&d Progress 13
small Molecules To Inhibit Beta Secretase For Alzheimer's Disease 14
product Description 14
mechanism Of Action 14
r&d Progress 14
comentis, Inc. - Pipeline Analysis 15
comentis, Inc. - Pipeline Products By Target 15
comentis, Inc. - Pipeline Products By Route Of Administration 16
comentis, Inc. - Pipeline Products By Molecule Type 17
comentis, Inc. - Pipeline Products By Mechanism Of Action 18
comentis, Inc. - Dormant Projects 19
comentis, Inc. - Locations And Subsidiaries 20
head Office 20
appendix 21
methodology 21
coverage 21
secondary Research 21
primary Research 21
expert Panel Validation 21
contact Us 21
disclaimer 22
list Of Tables
comentis, Inc., Key Information 4
comentis, Inc., Key Facts 4
comentis, Inc. - Pipeline By Indication, 2015 6
comentis, Inc. - Pipeline By Stage Of Development, 2015 7
comentis, Inc. - Monotherapy Products In Pipeline, 2015 8
comentis, Inc. - Phase Ii, 2015 9
comentis, Inc. - Preclinical, 2015 10
comentis, Inc. - Pipeline By Target, 2015 15
comentis, Inc. - Pipeline By Route Of Administration, 2015 16
comentis, Inc. - Pipeline By Molecule Type, 2015 17
comentis, Inc. - Pipeline Products By Mechanism Of Action, 2015 18
comentis, Inc. - Dormant Developmental Projects,2015 19
list Of Figures
comentis, Inc. - Pipeline By Top 10 Indication, 2015 6
comentis, Inc. - Pipeline By Stage Of Development, 2015 7
comentis, Inc. - Monotherapy Products In Pipeline, 2015 8
comentis, Inc. - Pipeline By Top 10 Target, 2015 15
comentis, Inc. - Pipeline By Top 10 Route Of Administration, 2015 16
comentis, Inc. - Pipeline By Top 10 Molecule Type, 2015 17
comentis, Inc. - Pipeline Products By Top 10 Mechanism Of Action, 2015 18
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
CoMentis, Inc. - Product Pipeline Review - 2015

3. Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
CoMentis, Inc. - Product Pipeline Review - 2015